PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Arrowhead Gains Full Rights to ARO-PNPLA3 for Patients with Non-Alcoholic Steatohepatitis

Arrowhead Gains Full Rights to ARO-PNPLA3 for Patients with Non-Alcoholic Steatohepatitis

February 16, 2023

Suresh Kannan, Chief Product Officer at Model N Shares Insights on the Fall 2022 Product Release of the Model N Revenue Cloud

Suresh Kannan, Chief Product Officer at Model N Shares Insights on the Fall 2022 Product Release of the Model N Revenue Cloud

February 16, 2023

Henlius Reports the US FDA Acceptance of BLA for Proposed Biosimilar Trastuzumab HLX02

Henlius Reports the US FDA Acceptance of BLA for Proposed Biosimilar Trastuzumab HLX02

February 16, 2023

Merck Signs an Exclusive License and Research Collaboration Agreement with Aqilion for Small Molecule Inhibitors of TAK1 Protein

Merck Signs an Exclusive License and Research Collaboration Agreement with Aqilion for Small Molecule Inhibitors of TAK1 Protein

February 16, 2023

BerGenBio Reports P-II Trial Results of BGB324 (bemcentinib) as 2L Treatment of Non-Small Cell Lung Cancer

BerGenBio Reports P-II Trial Results of BGB324 (bemcentinib) as 2L Treatment of Non-Small Cell Lung Cancer

February 16, 2023

Xilis Collaborated with MD Anderson to Advance Novel Technology and Advances Therapeutic Development

Xilis Collaborated with MD Anderson to Advance Novel Technology and Advances Therapeutic Development

February 16, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us